{Reference Type}: Journal Article
{Title}: Characterization of intracranial compliance in healthy subjects using a noninvasive method - results from a multicenter prospective observational study.
{Author}: Ocamoto GN;da Silva LN;da Silva Rocha Tomaz C;Hisatugu MT;Frigieri G;Cardim D;Gonçalves RL;Russo TL;de Amorim RLO;
{Journal}: J Clin Monit Comput
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 20
{Factor}: 1.977
{DOI}: 10.1007/s10877-024-01191-w
{Abstract}: <B>OBJECTIVE: </B>An FDA-approved non-invasive intracranial pressure (ICP) monitoring system enables the assessment of ICP waveforms by revealing and analyzing their morphological variations and parameters associated with intracranial compliance, such as the P2/P1 ratio and time-to-peak (TTP). The aim of this study is to characterize intracranial compliance in healthy volunteers across different age groups.<BR><B>METHODS: </B>Healthy participants, both sexes, aged from 9 to 74 years old were monitored for 5 min in the supine position at 0º. Age was stratified into 4 groups: children (≤ 7 years); young adults (18 ≤ age ≤ 44 years); middle-aged adults (45 ≤ age ≤ 64 years); older adults (≥ 65 years). The data obtained was the non-invasive ICP waveform, P2/P1 ratio and TTP.<BR><B>RESULTS: </B>From December 2020 to February 2023, 188 volunteers were assessed, of whom 104 were male, with a median (interquartile range) age of 41 (29-51), and a median (interquartile range) body mass index of 25.09 (22.57-28.04). Men exhibited lower values compared to women for both the P2/P1 ratio and TTP (p < 0.001). There was a relative rise in both P2/P1 and TTP as age increased (p < 0.001).<BR><B>CONCLUSIONS: </B>The study revealed that the P2/P1 ratio and TTP are influenced by age and sex in healthy individuals, with men displaying lower values than women, and both ratios increasing with age. These findings suggest potential avenues for further research with larger and more diverse samples to establish reference values for comparison in various health conditions.<BR><B>BACKGROUND: </B>Brazilian Registry of Clinical Trials (RBR-9nv2h42), retrospectively registered 05/24/2022. UTN: U1111-1266-8006.